Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F21JC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $87,878
Award facts
- Contract value 100% obligated
- $87,878.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $87,878.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 27, 2026, for the supply of Biktarvy 50-200-25 mg tablets in quantities of 30 units. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of January 28, 2026, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's parent company, Cencora, Inc. (formerly AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031, serving as the primary vehicle for pharmaceutical supply to military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical products to federal agencies, particularly the Department of Defense and Department of Veterans Affairs. The company's federal contract portfolio demonstrates extensive experience fulfilling government procurement requirements for prescription medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a subsidiary of Cencora, Inc., the company leverages its parent organization's comprehensive pharmaceutical supply chain capabilities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide.
Quick answers
Who was awarded contract SPE2DR26F21JC?
SPE2DR26F21JC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F21JC worth?
The government has obligated $87,878 on SPE2DR26F21JC.
Is contract SPE2DR26F21JC an order under another contract?
Yes. SPE2DR26F21JC is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21JC competed?
The extent of competition for SPE2DR26F21JC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award